Archer Investment Corporation’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Archer Investment Corporation’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-203	Closed	-$22.7K	–	865
2021 Q4	$22.7K	Hold	203	–	–	0.01%	470
2021 Q3	$25.5K	Hold	203	–	–	0.01%	441
2021 Q2	$27.5K	Hold	203	–	–	0.01%	393
2021 Q1	$27.5K	Buy	+203	New	+$30.4K	0.01%	427
2020 Q4	–	Sell	-50	Closed	-$5.57K	–	760
2020 Q3	$5.57K	Hold	50	–	–	﹤0.01%	497
2020 Q2	$5.6K	Buy	+50	New	+$4.92K	﹤0.01%	495

Other funds holding XBI

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

MCMC

Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

Archer Investment Corporation's XBI Position: Q1 2022 in Review

Archer Investment Corporation sold out of State Street SPDR S&P Biotech ETF (XBI) in Q1 2022, closing a stake of 203 shares — an estimated $22.7K sold.

Archer Investment Corporation first reported a position in XBI in Q2 2020 and held it in 6 quarters. The position peaked at $27.5K in Q1 2021. 703 funds tracked by Wall St. Rank hold XBI as of Q1 2022.

Archer Investment Corporation reported no remaining State Street SPDR S&P Biotech ETF position as of Q1 2022 after selling out during the quarter.
Archer Investment Corporation sold 203 State Street SPDR S&P Biotech ETF shares in Q1 2022, an estimated $22.7K.
Archer Investment Corporation first reported a position in State Street SPDR S&P Biotech ETF in Q2 2020 and held it in 6 quarters.
Archer Investment Corporation's State Street SPDR S&P Biotech ETF position peaked at $27.5K in Q1 2021.
703 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2022.

Based on Archer Investment Corporation's 13F filing for Q1 2022, filed 12 May 2022.